<DOC>
	<DOCNO>NCT00516737</DOCNO>
	<brief_summary>The purpose study test effectiveness rizatriptan benzoate early treatment acute migraine attack .</brief_summary>
	<brief_title>Study Test Rizatriptan Early Treatment Acute Migraine ( 0462-081 )</brief_title>
	<detailed_description />
	<mesh_term>Migraine Disorders</mesh_term>
	<mesh_term>Rizatriptan</mesh_term>
	<criteria>Greater one year history migraine Attacks typically mild begin progress moderate severe Experience 14 migraine attack per month More 15 headache day per month Heart disease Uncontrolled high blood pressure</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2015</verification_date>
</DOC>